GB925538A - Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives - Google Patents

Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives

Info

Publication number
GB925538A
GB925538A GB793161A GB793161A GB925538A GB 925538 A GB925538 A GB 925538A GB 793161 A GB793161 A GB 793161A GB 793161 A GB793161 A GB 793161A GB 925538 A GB925538 A GB 925538A
Authority
GB
United Kingdom
Prior art keywords
compounds
give
benzyloxyethyl
piperazine
aminoalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB793161A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12966A external-priority patent/US3192204A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB925538A publication Critical patent/GB925538A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/90Xanthenes with hydrocarbon radicals, substituted by amino radicals, directly attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
GB793161A 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives Expired GB925538A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12966A US3192204A (en) 1960-03-07 1960-03-07 Trifluoromethylthiaxanthene and -xanthene derivatives
US2693960A 1960-05-05 1960-05-05

Publications (1)

Publication Number Publication Date
GB925538A true GB925538A (en) 1963-05-08

Family

ID=26684247

Family Applications (2)

Application Number Title Priority Date Filing Date
GB793161A Expired GB925538A (en) 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives
GB1914062A Expired GB925539A (en) 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1914062A Expired GB925539A (en) 1960-03-07 1961-03-03 Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives

Country Status (5)

Country Link
BE (1) BE600735A (enExample)
DE (2) DE1210890B (enExample)
FR (1) FR1002M (enExample)
GB (2) GB925538A (enExample)
SE (1) SE333573B (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157658A (en) * 1963-07-05 1964-11-17 Searle & Co 1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
US3159636A (en) * 1963-07-05 1964-12-01 Searle & Co 1-amino-4-(xanthenyl and thioxanthenyl) piperazines
US5104858A (en) * 1988-09-29 1992-04-14 Yale University Sensitizing multidrug resistant cells to antitumor agents
WO2005037820A1 (en) * 2003-10-17 2005-04-28 Laboratorio Chimico Internazionale S.P.A. Process for the preparation of z-flupentixol
WO2005105145A1 (en) 2004-04-30 2005-11-10 Bkg Pharma Aps Treatment of infectious diseases
EP2301545A1 (en) 2007-01-05 2011-03-30 BKG Pharma ApS Thioxanthene derivatives for use in the treatment of infectious diseases
EP2374450A1 (en) 2010-04-06 2011-10-12 H. Lundbeck A/S Flupentixol compositions
CN104693173A (zh) * 2015-03-09 2015-06-10 广东帅广医药有限公司 一种盐酸氟哌噻吨的制备方法
CN107987053A (zh) * 2017-12-08 2018-05-04 重庆植恩药业有限公司 一种高纯度z型盐酸氟哌噻吨的制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196549A (en) * 1991-06-11 1993-03-23 E. I. Du Pont De Nemours And Company Polyethers based on 9,9-bis-perfluoroalkyl-3,6-dihydroxy-xanthene or 9-aryl-9-perfluoroalkyl-3,6-dihydroxy-xanthane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1044103B (de) * 1956-06-12 1958-11-20 Hoffmann La Roche Verfahren zur Herstellung von Xanthen- bzw. Thioxanthenderivaten
AT202143B (de) * 1956-12-28 1959-02-10 American Cyanamid Co Verfahren zur Herstellung von neuen Dimethylaminopropylidenxanthenen
AT202152B (de) * 1956-12-28 1959-02-10 American Cyanamid Co Verfahren zur Herstellung von neuen Dimethylaminopropylidenthiaxanthenen.
FR1173489A (fr) * 1957-04-04 1959-02-25 Merck & Co Inc Thiaxanthènes substitués

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157658A (en) * 1963-07-05 1964-11-17 Searle & Co 1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
US3159636A (en) * 1963-07-05 1964-12-01 Searle & Co 1-amino-4-(xanthenyl and thioxanthenyl) piperazines
US5104858A (en) * 1988-09-29 1992-04-14 Yale University Sensitizing multidrug resistant cells to antitumor agents
WO2005037820A1 (en) * 2003-10-17 2005-04-28 Laboratorio Chimico Internazionale S.P.A. Process for the preparation of z-flupentixol
WO2005105145A1 (en) 2004-04-30 2005-11-10 Bkg Pharma Aps Treatment of infectious diseases
EP2260870A2 (en) 2004-04-30 2010-12-15 BKG Pharma ApS Treatment of infectious diseases with combinations of a thioxanthene derivative with an anti-infective agent
EP2301545A1 (en) 2007-01-05 2011-03-30 BKG Pharma ApS Thioxanthene derivatives for use in the treatment of infectious diseases
EP2374450A1 (en) 2010-04-06 2011-10-12 H. Lundbeck A/S Flupentixol compositions
CN104693173A (zh) * 2015-03-09 2015-06-10 广东帅广医药有限公司 一种盐酸氟哌噻吨的制备方法
CN107987053A (zh) * 2017-12-08 2018-05-04 重庆植恩药业有限公司 一种高纯度z型盐酸氟哌噻吨的制备方法
CN107987053B (zh) * 2017-12-08 2023-04-14 植恩生物技术股份有限公司 一种高纯度z型盐酸氟哌噻吨的制备方法

Also Published As

Publication number Publication date
FR1002M (fr) 1961-12-18
BE600735A (fr) 1961-08-28
DE1518325B1 (de) 1970-08-27
GB925539A (en) 1963-05-08
DE1210890B (de) 1966-02-17
SE333573B (enExample) 1971-03-22

Similar Documents

Publication Publication Date Title
GB925538A (en) Improvements in or relating to trifluoromethylthiaxanthene and -xanthene derivatives
GB932494A (en) Xanthenes and thiaxanthenes and method of producing the same
HUT39175A (en) Process for producing 7-/3-aryl-1-piperazinyl/- and 7-/3-cyclohexyl-1-piperazinyl/-3-quinoline-carboxylic acids and pharmaceutical compositions containing them as active agents
GB1023214A (en) Carbocyclic hydroxyamines
PE20040768A1 (es) Derivados de arilen-(2-amino-fenil)-carboxamida como inhibidores de la histona desacetilasa (hdac)
ES2060667T3 (es) Derivados de aralquilaminoalcoxifenilo, procedimiento de preparacion y composiciones que los contienen.
SE7408245L (enExample)
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
ATE48993T1 (de) Aetheroxidderivate von zyklopropylphenolen.
ES381580A1 (es) Procedimiento para la preparacion de nuevos derivados de a-cidos ariloxi y ariltio-aceticos.
ES435567A1 (es) Un procedimiento para la preparacion de nuevos derivados de acidos xantona-carboxilicos disustitudos.
ES2035102T3 (es) Compuestos que contienen hierro biodisponible, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES405648A1 (es) Procedimiento para la preparacion de nuevos acidos 4 - (4 -bifenilil) - 4 - hidroxi - butiricos, sus esteres o lacto- nas.
ES415952A1 (es) Procedimiento de preparacion de n(dietilaminoetil)-2-meto- xi-4-amino-5-clorobenzamina.
ES409089A1 (es) Procedimiento para la preparacion de nuevas 6-aza-3h-1,4- benzodiazepinas.
ES441434A1 (es) Proceso de obtencion de derivados del acido 2-naftil-butiri-co de actividad terapeutica.
MX3366E (es) Procedimiento para la preparacion de acidos omega-(6,11-dihidro-11-oxodibenz ( b,e,) oxepin-2-il) - alcanoicos
GB923357A (en) Cinnamamide derivatives and process for their preparation
ES404787A1 (es) Un procedimiento para la preparacion de nuevos compuestos de acidos xantonacarboxilicos sustituidos.
ES8603426A1 (es) Procedimiento para preparar derivados de pirazolpiridina.
ES430320A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidroxifenilalanina.
DK1144354T3 (da) Anhydridstabilisering
ES382190A1 (es) Procedimiento para la preparacion de nuevos derivados de tiepina y oxepina.
ES426948A1 (es) Procedimiento para la preparacion de nuevas 1,4-benzodiaze-pinas.
ES435673A1 (es) Un procedimiento para la preparacion de compuestos de acido xantona-carboxilico sustituido.